Sortilin (approximately 95 kDa) is a member of the recently discovered family of Vps10p-domain receptors, and is expressed in a variety of tissues, notably brain, spinal cord and muscle. It acts as a receptor for neurotensin, but predominates in regions of the nervous system that neither synthesize nor respond to this neuropeptide, suggesting that sortilin has additional roles. Sortilin is expressed during embryogenesis in areas where nerve growth factor (NGF) and its precursor, proNGF, have well-characterized effects. These neurotrophins can be released by neuronal tissues, and they regulate neuronal development through cell survival and cell death signalling. NGF regulates cell survival and cell death via binding to two different receptors, TrkA and p75NTR (ref. 10). In contrast, proNGF selectively induces apoptosis through p75NTR but not TrkA. However, not all p75NTR-expressing cells respond to proNGF, suggesting that additional membrane proteins are required for the induction of cell death. Here we report that proNGF creates a signalling complex by simultaneously binding to p75NTR and sortilin. Thus sortilin acts as a co-receptor and molecular switch governing the p75NTR-mediated pro-apoptotic signal induced by proNGF.
Sortilin belongs to a growing family of multiligand type-1 receptors with homology to the yeast receptor Vps10p. Based on structural features and sortilin's intracellular predominance, we have proposed it to be a sorting receptor for ligands in the synthetic pathway as well as on the cell membrane. To test this hypothesis we examine here the cellular traf®cking of chimeric receptors containing constructs of the sortilin tail. We report that sorting signals conforming to YXXF and dileucine motifs mediate rapid endocytosis of sortilin chimeras, which subsequently travel to the trans-Golgi network, showing little or no recycling. Furthermore, we found that cation-independent mannose 6-phosphate receptor (MPR300)±sortilin chimeras, expressed in mannose 6-phosphate receptor knockout cells, were almost as ef®cient as MPR300 itself for transport of newly synthesized b-hexosaminidase and b-glucuronidase to lysosomes, and established that the sortilin tail contains potent signals for Golgi±endosome sorting. Finally, we provide evidence suggesting that sortilin is the ®rst example of a mammalian receptor targeted by the recently described GGA family of cytosolic sorting proteins, which condition the Vps10p-mediated sorting of yeast carboxypeptidase Y.
Receptor-associated protein (RAP) is an endoplasmic reticulum/Golgi protein involved in the processing of receptors of the low density lipoprotein receptor family. A ϳ95-kDa membrane glycoprotein, designated gp95/ sortilin, was purified from human brain extracts by RAP affinity chromatography and cloned in a human cDNA library. The gene maps to chromosome 1p and encodes an 833-amino acid type I receptor containing an N-terminal furin cleavage site immediately preceding the N terminus determined in the purified protein. Gp95/sortilin is expressed in several tissues including brain, spinal cord, and testis. Gp95/sortilin is not related to the low density lipoprotein receptor family but shows intriguing homologies to established sorting receptors: a 140-amino acid lumenal segment of sortilin representing a hitherto unrecognized type of extracellular module shows extensive homology to corresponding segments in each of the two lumenal domains of yeast Vps10p, and the extreme C terminus of the cytoplasmic tail of sortilin contains the casein kinase phosphorylation consensus site and an adjacent dileucine sorting motif that mediate assembly protein-1 binding and lysosomal sorting of the mannose-6-phosphate receptors. Expression of a chimeric receptor containing the cytoplasmic tail of gp95/ sortilin demonstrates evidence that the tail conveys colocalization with the cation-independent mannose-6-phosphate receptor in endosomes and the Golgi compartment.Sorting of newly synthesized lysosomal enzymes from the Golgi compartment to late endosomes in eukaryotic cells is a sophisticated transport process involving specific sorting receptors in the trans-Golgi network. In mammals, the 46-and 275-kDa mannose-6-phosphate (M6P) 1 receptors are the known sorting receptors that bind to phosphorylated mannose residues in lysosomal hydrolases (1). In yeast, a M6P-independent sorting pathway has been demonstrated by identification of the vacuolar protein-sorting 10 protein (Vps10p) (2) and a highly homologous protein encoded by the yeast VTH2 gene (3). Both are capable of targeting yeast carboxypeptidase Y to lysosomes (2, 3). Mammalian counterparts to these sorting receptors have so far not been identified. However, studies of I-cell disease patients suggest that mammals may sort lysosomal enzymes by alternative mechanisms (4 -9). The 40-kDa endoplasmic reticulum/Golgi receptor-associated protein (RAP) assists folding and processing of the cysteine-rich low density lipoprotein (LDL) receptor class A repeats in receptors of the LDL receptor family (10 -13). In addition to the high affinity binding to the LDL receptor family proteins and the newly identified LDL receptor type A repeat containing receptor sorLA/LR11 (14, 15), RAP binds calmodulin and is phosphorylated by calmodulin-dependent kinase II and casein kinase II (16). Recently, independent observations have shown the binding of RAP to an approximately 100-kDa protein expressed in osteosarcoma (17) and Chinese hamster ovary cells (18).In the present study we have identified, pu...
␣-Synuclein has been implicated in the pathogenesis of several neurodegenerative disorders based on the direct linking of missense mutations in ␣-synuclein to autosomal dominant Parkinson's disease and its presence in Lewy-like lesions. To gain insight into ␣-synuclein functions, we have investigated whether it binds neuronal proteins and modulates their functional state. The microtubule-associated protein tau was identified as a ligand by ␣-synuclein affinity chromatography of human brain cytosol. Direct binding assays using 125 I-labeled human tau40 demonstrated a reversible binding with a IC 50 about 50 pM. The interacting domains were localized to the C terminus of ␣-synuclein and the microtubule binding region of tau as determined by protein fragmentation and the use of recombinant peptides. High concentrations of tubulin inhibited the binding between tau and ␣-synuclein. Functionally, ␣-synuclein stimulated the protein kinase A-catalyzed phosphorylation of tau serine residues 262 and 356 as determined using a phospho-epitope-specific antibody. We propose that ␣-synuclein modulates the phosphorylation of soluble axonal tau and thereby indirectly affects the stability of axonal microtubules.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.